Recently, we identified a patient with an infantile sacrococcygeal teratoma and a constitutional t(12;15)(q13;q25). Here, we show that, as a result of this chromosomal translocation, the SUMO/Sentrinspecific protease 1 gene (SENP1 ) on chromosome 12 and the embryonic polarity-related mesoderm development gene (MESDC2 ) on chromosome 15 are disrupted and fused. Both reciprocal SENP1 -MESDC2 (SEME) and MESDC2 -SENP1 (MESE) fusion genes are transcribed in tumor-derived cells and their open reading frames encode aberrant proteins. As a consequence of this, and in contrast to wild-type (WT) MESDC2, the translocation-associated SEME protein is no longer targeted to the endoplasmatic reticulum, leading to a presumed loss-of-function as a chaperone for the WNT co-receptors LRP5 and/or LRP6. Ultimately, this might lead to abnormal development and/or routing of germ cell tumor precursor cells. SUMO, a posttranslational modifier, plays an important role in several cellular key processes and is cleaved from its substrates by WT SENP1. Using a PML desumoylation assay, we found that translocation-associated MESE proteins exhibit desumoylation capacities similar to those observed for WT SENP1. We speculate that spatio-temporal disturbances in desumoylating activities during critical stages of embryonic development might have predisposed the patient. Together, the constitutional t(12;15)(q13;q25) translocation revealed two novel candidate genes for neonatal/infantile GCT development: MESDC2 and SENP1.
INTRODUCTION
Human germ cell tumors (GCTs) can arise at various ages, in both sexes, at different body locations and vary with respect to clinical outcome, histology and genetic constitution (1 -3) . GCTs are most prevalent in the testis of young adult males. We and others have suggested that GCTs of infants and neonates may represent a distinct subgroup (2 -8) . These latter tumors are relatively rare, mainly arise in the sacral/sacrococcygeal region and, at a lower frequency, in the gonads and along the midline of the body (3) . How these tumors develop and from which precursor cells they originate is still a matter of debate. A common precursor cell type, however, has been suggested for infantile gonadal and extra-gonadal GCTs (9) . The main histological infantile subtypes include teratomas with mesodermal, ectodermal and endodermal components and yolk sac tumors with yolk sac endodermal components. Teratoma development resembles embryogenesis in various aspects (10, 11) . Therefore, these latter tumors have been used as model systems to study both early embryonic and tumorigenic processes (12, 13) .
Currently available information on the cytogenetic constitution of neonatal and infantile GCTs indicates that teratomas are mostly diploid with only minor non-recurrent chromosomal anomalies. In contrast, infantile yolk sac tumors exhibit several major recurrent chromosomal aberrations (7,8,14 -18) . Overall, the most frequent cytogenetic anomaly in GCTs is the i(12p) chromosome. This marker chromosome is almost exclusively present in testicular GCTs of juveniles and adults (19) . Several recurrent genomic anomalies in both neonatal/infantile and juvenile/adult GCTs are currently under investigation (20 -24) . So far, however, no gene that is causally related to GCT development has been unambiguously identified neither for the infantile type nor for the adult type.
Using linkage analysis, Rapley et al. (25) identified a locus on Xq27 for familial testicular germ cell cancer. Additional candidate regions harboring putative genes for familial GCT development include 16p13, 18q22-qter and 12q12 -13 (26) . Together with the 12q22 region, the 12q12-13 region was found to be frequently deleted in sporadic GCTs as well (27 -29) . Linkage and CGH studies typically result in the identification of relatively large tumor-related genomic intervals containing numerous candidate genes. Recurrent, apparently balanced chromosomal anomalies, however, provide an opportunity to overcome this problem. Constitutional chromosome translocations have been widely employed to identify candidate genes in various (hereditary) cancer syndromes (30 -33) . Recently, we detected a patient with an infantile sacrococcygeal teratoma and a constitutional t(12;15)(q13;q25) (34) . Here, we show that this translocation results in a fusion of the SUMO/Sentrin-specific protease 1 gene (SENP1 ) on 12q13 and the embryonic polarity-related mesoderm development gene (MESDC2 ) on 15q25. The putative implications of this novel gene fusion in the context of GCT development are discussed.
RESULTS

SENP1 is disrupted by the 12q13 breakpoint
Previously, we identified a YAC clone (CEPH-919G8) that spans the constitutional t(12;15)(q13;q25) breakpoint at 12q13 (5) . In order to refine this breakpoint region, a PAC contig was assembled that corresponds to this YAC clone (Fig. 1A) . Fluorescence in situ hybridization (FISH) analysis on metaphase spreads of t(12;15)(q13;q25)-positive cells revealed that PAC clones RP1-316M24, RP1-130F5 and RP3-197B17 map proximal to the breakpoint and that, in contrast, RP1-228P16 turned out to be a breakpoint spanning clone. This finding is in full concordance with our subsequent array CGH-based mapping data (35) . The complete sequence of RP1-228P16 is available in GenBank (accession no. AC004801) and, according to the May 2004 human genome assembly freeze (http://genome.ucsc.edu/), it encompasses four positional candidate genes: MGC5576 (a hypothetical gene), COL2A1, SENP1 and PFKM (Fig. 1A) .
To facilitate further refinement of the chromosomal breakpoint position in RP1-228P16, the t(12;15)(q13;q25)-associated chromosomes were segregated by generating Chinese hamster -human somatic cell hybrids. These hybrid cell lines with the normal chromosome 12, the derivative chromosome 12 [der (12) ] or the derivative chromosome 15 [der (15) ] were employed for STS-content mapping using specific PCR primer sets from preselected regions within RP1-228P16. The original t(12;15)(q13;q25)-positive lymphoblastoid cell line was included as a positive control. By doing so, the breakpoint interval could be reduced to a 3.6 kb genomic interval (data not shown).
In order to confirm these PCR results and to further narrow down the breakpoint region, Southern blot analysis was performed using HindIII and Bgl II digested DNAs extracted from the original and hybrid cell lines. A PCR fragment generated by one of the breakpoint-flanking primer sets (228p16-38) was used as probe. As expected, this probe hybridized to both HindIII and Bgl II wild-type (WT) fragments of 4.1 and 6.7 kb in the t(12;15)(q13;q25)-positive cell line and the chromosome 12-positive hybrid cell line, respectively (Fig. 1B, lanes 1 and 2) . In addition, aberrantly hybridizing fragments were observed in the HindIII (.12 kb) and Bgl II (10 kb) digested DNAs of the t(12;15)(q13;q25)-positive cell line and the der(15)-positive hybrid cell line (lanes 1 and 3, respectively). These shifted fragments were absent in the der(12)-positive hybrid cell line (lane 4), indicating that they originate from the der (15) . Together, the PCR and Southern blot analysis results reduced the 12q13 breakpoint region to a 2.4 kb genomic interval. Analysis of its sequence using the UCSC human genome browser (May 2004 freeze) revealed that it is located within the second intron of one of the four earlier mentioned candidate genes; SENP1 ( Fig. 2A) . SENP1 belongs to the family of SUMO/Sentrinspecific proteases which are known to be involved in the cleavage of SUMO proteins from their substrates (36) . The SENP1 gene is 63 kb in size and encodes an mRNA of 4.7 kb (GenBank accession no. NM_014554). The May 2004 freeze of the UCSC human genome browser reveals several different mRNA splice variants that differ in their first exons, the length of their 3 0 -untranslated region (3 0 -UTRs) and/or the number of (additional) exons. The largest open reading frame (ORF) encodes a 643 amino acids protein that corresponds to the WT protein described by Gong et al. (36) .
SENP1 is fused to MESDC2 at 15q25
On the basis of the localization of the 12q13 breakpoint within SENP1, we set out to identify the breakpoint sequences present at 15q25. To this end, 3 0 -rapid amplification of cDNA ends (RACE) analysis was performed using the SENP1 breakpoint information as a starting point. cDNAs generated from the t(12;15)(q13;q25)-positive lymphoblastoid cell line and, as a control, cDNAs from an unrelated lymphoblastoid cell line without a t(12;15)(q13;q25) were used. Aberrant PCR-fragments only present in the t(12;15)(q13;q25)-positive cell line were cloned, sequenced and analyzed (Fig. 2B ). This resulted in the identification of chimeric transcripts, consisting of SENP1 sequences fused to sequences from MESDC2, a gene located at the 15q25 breakpoint region. More specifically, the MESDC2 gene is located in BAC clone RP11-775C24, again completely in line with our array CGH-based mapping data (35) .
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Human Molecular Genetics, 2005, Vol. 14, No. 14 The breakpoint in the MESDC2 gene appeared to be located within its first intron ( Fig. 2A) . MESDC2 is an embryonic polarity-related gene (37,38) of 14 kb in size and encodes a 4.2 kb mRNA corresponding to a deduced protein of 234 amino acids (GenBank accession no. D42039). Also, for this gene, additional mRNAs that differ in length at their 3 0 -UTR are reported in the May 2004 freeze of the UCSC human genome browser. The presence of SENP1 -MESDC2 fusion transcripts (here referred to as SEME) in the t(12;15)(q13;q25)-positive cell line was confirmed by reverse transcription-polymerase chain reaction (RT-PCR). Similarly, the presence of SEME was confirmed in the primary tumor sample of the patient as well (Fig. 2C , first panel). In addition, RT -PCR showed the presence of the reciprocal MESDC2 -SENP1 transcript (referred to as MESE) and the WT SENP1 and MESDC2 transcripts in the primary tumor sample (Fig. 2C ).
The t(12;15)(q13;q25)-positive lymphoblastoid cell line that we used for mapping of the breakpoints was derived from the patient's father. In order to verify whether the genomic breakpoints identified in this cell line are in conformity to those in the patient, we performed PCR analysis on genomic DNAs extracted from the tumor material of the patient and the t(12;15)(q13;q25)-positive cell line. In both cases, similar PCR products were obtained (Fig. 2D) , and their sequences revealed that both breakpoints were identical at the base-pair level, thereby, ruling out breakpoint-flanking duplications and/or deletions in the patient due to incomplete pairing and unequal crossing over of the respective derivative chromosomes at the breakpoints during meiotic division. In addition, we sequenced the complete ORFs of SENP1 and MESDC2 from the tumor-derived DNA and no additional (somatic) mutations were detected.
MESE has retained desumoylating activity
The reciprocal MESE fusion transcript is composed of the first exon of MESDC2 followed by exons 3 -18 of SENP1. Owing to the translocation, the original start codon of SENP1 (36) is lost and two alternative ORFs are predicted for this MESE transcript. Depending on which ATG is used as a start codon, the encoded protein represents either an aberrant MESDC2 protein with 71 in-frame N-terminal amino acids followed by six additional amino acids or a protein that is almost completely composed of SENP1 except for the second amino acid at the N-terminus (here referred to as MESE 1.2). Using RT -PCR, we detected an additional MESE transcript containing an aberrant exon 1 of MESDC2 (lacking 199 bp at the 3 0 end) and exons 3-18 of SENP1 in the t(12;15)(q13;q25)-positive lymphoblastoid cell line. The predicted ORF of this transcript encodes a putative protein that lacks eight amino acids at the N-terminus when compared with WT SENP1 (here referred to as MESE 11.4). The two aberrant SENP1 proteins (MESE 1.2 and 11.4) encoded by the largest predicted ORFs contain the known SENP1 functional domains, i.e. the nuclear localization signal and the protease domain (Fig. 3) (36, 39) .
SENP1 is a SUMO/Sentrin-specific protease, which can cleave SUMO-1 from target proteins such as PML (36, 40) . To examine whether the MESE proteins have retained this functional capacity, we performed desumoylation assays using PML as a target. Therefore, COS-1 cells were transfected with one or more of the following expression constructs: His-PML, Ha -SUMO-1, MESE-VSV (1.2 or 11.4), WT SENP1 -VSV and/or a control empty vector (Fig. 4) . His -PML proteins with or without a conjugated Ha -SUMO-1 protein were purified from the cell lysates by 2) together with PML and SUMO-1 (lanes 5 and 6) did not show any sumoylated isoforms of PML, indicating that although both MESE proteins were expressed at a lower level than WT SENP1 ( Fig. 4 ; SENP1 variants), they were still fully capable of desumoylating PML.
Anomalous subcellular localization of SEME WT MESDC2 contains a putative N-terminal signal sequence and a non-conserved C-terminal ER-retention signal (Fig. 3) . Previously, it was shown that a flag-tagged mouse homologue of MESDC2 co-localizes with the luminal ER protein calreticulin in COS-1 cells (38) . In this study, we independently confirmed this localization by showing that a VSV-tagged human MESDC2 co-localizes with the ER protein PDI in HeLa cells (Fig. 5A) . The translocation-related SEME fusion transcript contains the first two exons of SENP1 and exons 2 and 3 of MESDC2. A predicted ORF encodes an MESDC2 protein that lacks 106 amino acids at the N-terminus when compared with WT MESDC2 (Fig. 3) . In addition, we detected a splice variant of SEME without the SENP1 exon 2 in the tumor material (SEME-2). The predicted ORF of this splice variant lacks 71 N-terminal MESDC2 amino acids and, instead, contains seven additional amino acids. Owing to the truncations, both SEME proteins lack the putative signal peptide that is required for the transport to the ER. Indeed, exogeneous expression of VSV-tagged SEME in HeLa cells revealed a diffuse staining pattern throughout the cytoplasm and no co-localization with PDI was observed (Fig. 5B) . Therefore, we conclude that SEME is not localized at or in the ER. Control empty vector cells failed to yield any signals using the anti-VSV and secondary antibodies (data not shown).
DISCUSSION
Recently, we presented a novel case of a sacrococcygeal teratoma from an infantile patient carrying a constitutional 
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Human Molecular Genetics, 2005, Vol. 14, No. 14 t(12;15)(q13;q25). LOH experiments confirmed the presence of both reciprocal derivative chromosomes in the tumor material (34) . In addition to this constitutional translocation, we identified one additional (somatic) cytogenetic aberration in this tumor, i.e. amplification of 20q and deletion of 20p (18) . As the 12q13 region is recurrently affected in human GCTs (27,28), we set out to characterize this constitutional t(12;15)(q13;q25) translocation in detail. Using positional cloning strategies, we found that the breakpoints on chromosome 12 and chromosome 15 disrupt two genes, i.e. SENP1 and MESDC2, respectively. This resulted in the formation of two reciprocal fusion genes: SENP1 -MESDC2 on the der(15) and MESDC2 -SENP1 on the der(12). Next to the respective WT genes, both fusion genes (here referred to as SEME and MESE ) appeared to be transcribed in the tumor tissue, and functional ORFs were predicted from them. SUMO/Sentrin is an ubiquitin-like protein that covalently attaches to lysine residues in substrate proteins as a post-translational modification. In vertebrates, three SUMO family members have been described, i.e. SUMO-1, -2 and -3 (41, 42) . In contrast to ubiquitin, SUMO does not target proteins for proteasomal destruction. Instead, SUMO modification appears to be involved in the regulation of various cellular key processes, including transcriptional regulation, nuclear transport, maintenance of genome integrity and signal transduction (43 -45) . The SENP1 gene was first identified by Gong et al. (36) and encodes a cysteine-specific protease that deconjugates SUMO-1 from its target proteins. A recent in vitro study showed that SENP1 can also preprocess SUMO-1, -2 and -3 from their precursor forms (46) . So far, seven SUMO-related proteases have been identified and deposited in the GenBank database (SENP1 -SENP7). These proteases are homologous at their C-termini, a region that contains a conserved protease domain, the HIS/ASP/CYS catalytic triad. On the basis of the differences in subcellular localization and mRNA expression patterns, substrate specificities have been suggested for the various SENP family members (39,47 -50) . Interestingly, one of the family members, SENP6 (SUSP1 ) was recently found to be disrupted and fused to the TCBA1 gene in the lymphoma-derived cell line HT-1 (51). Also, SENP1 was detected as one of the 30 overexpressed genes in thyroid oncocytic tumors, using a two-step differential RT -PCR assay (52) . Together with the present study, these findings strengthen a possible role for this protease family in cancer development.
Through a PML desumoylation assay, we established that the two translocation-associated MESE proteins (differing in only eight or one amino acid(s) from WT SENP1, respectively) exhibited desumoylation capacities similar to that observed for WT SENP1. In addition, the MESDC2 -SENP1 fusion gene is under the control of the MESDC2 promoter. Therefore, we speculate that spatio-temporal disturbances in desumoylating activities during critical stages of embryonic development may lead to an abnormal regulation of gene transcription, nuclear transport, genome integrity and/or signal transduction in GCT precursor cells. In addition to these promoter-swap related phenomena, it should be noted that N-terminal truncation of the SENP1 protein may have additional in vivo effects on its biological activity and/or its substrate specificity. Such disturbances may have predisposed our patient to GCT development.
The mouse homologue of MESDC2 (aliases: Mesd in mouse, KIAA0081 in human and BOCA in fly) was first identified as a candidate gene present in the mouse proximal albino deletion interval, which is critical for mesoderm differentiation and polarity during embryonic development (37) . Embryos homozygous for this deletion are lethal, fail to develop mesodermal structures and do not form a primitive streak (53) . Hsieh et al. (38) demonstrated by transgene rescue that Mesd is the gene that is responsible for the polarity defects and embryonic lethality in these mice. Subsequently, transient expression in COS-1 cells demonstrated that Mesd may act as a chaperone located in the ER, which facilitates the membrane localization and prevents the aggregation of LDL receptor family members like the WNT co-receptors LRP5 and LRP6 (38, 54) . In this study we show that, in contrast to WT MESDC2, the translocation-associated SEME protein is no longer restricted to the ER. Consequently, it may have lost its capacity to act as a chaperone for the LDL receptors LRP5 and/or LRP6. Like the MESDC2 -SENP1 fusion gene, the SENP1 -MESDC2 fusion gene also has undergone a promoter swap. Again, such a swap may have spatio-temporal consequences during early embryogenesis, including an abnormal development and/or routing of GCT precursor cells. Obviously, additional studies are required to establish a definite role for desumoylation, LDL receptor aggregation or both, on the (de)regulation of GCT precursor cells. This novel constitutional chromosome translocation, however, appears to have revealed novel leads to candidate genes and pathways critical to the development of neonatal/infantile GCTs.
MATERIALS AND METHODS
Patient material and somatic cell hybrids
Peripheral blood lymphocytes were used (informed consent) to generate an immortal t(12;15)(q13;q25)-positive cell line after in vitro Epstein -Barr virus transformation using standard procedures. For the preparation of somatic cell hybrids, these t(12;15)(q13;q25)-positive cells were fused with thymidine kinase-deficient Chinese hamster A3 cells as described earlier (55) . Subsequently, independent somatic cell hybrids were isolated after hypoxanthine -aminoterine -thymidine (HAT) selection and their human chromosomal constitution was established through karyotyping, FISH analysis and PCRscreening with primers D12S63, D12S85, D12S1661 and D12S1701. Hybrid cell lines that contained the normal chromosome 12, the der(15) or the der(12), respectively, were selected for further analysis. No other chromosome 12 or chromosome 15 material was detected in these selected hybrid cell lines.
FISH analysis
Metaphase spreads from the t(12;15)(q13;q25)-positive cell line and its derived somatic cell hybrids were used for FISH analysis. Probe labeling, slide preparation and hybridization were performed essentially as described earlier (34, 56) . The following clones were used for FISH analysis: RP1-316M24, RP1-130F5, RP3-197B17 and RP1-228P16 (BACPAC Resources, Oakland, CA, USA)
A Zeiss epifluorescence microscope equipped with appropriate filters was used for visual examination of the slides. Digital images were captured using a high-performance cooled CCD camera (Photometrics) coupled to a Macintosh Quadra 950 computer and processed using the Oncor-image software (Gaithersburgh, MD, USA).
PCR and Southern blot analysis
Genomic DNAs were isolated as described previously (57) . For mapping of the 12q13 breakpoint, genomic DNAs of the parental and hybrid cell lines were analyzed using different primer sets, including those flanking the breakpoint, i.e. 228p16-38f (TCACTTCTAGTGGCTGCACC) and 228p16-38r (AAACCCATTCTTTCACTACAGC), and 228p16-41f (GAGTTCTTTGAGAACAGTACG) and 228p16-41r (ATAGCACAGACATCTTAGAGC). The PCR fragment of primer set 228p16-38 was subsequently labeled with [a-32 P]dCTP by random priming and used as a probe on Southern blots containing Bgl II-and HindIII-digested parental and hybrid cell-derived DNAs. RT -PCR was performed using Superscript II (Life Technologies, Gaithersburg, MD, USA), 5 mg of total RNA, the oligodT primer (AAGGATCCGTCGACATCTTTTTTTTT TTTTTTTT) and a random hexamer mix (Invitrogen, Breda, The Netherlands), again according to the instructions of the manufacturer. 3 0 -RACE analysis was carried out in two PCR steps. The first PCR was performed with a specific forward primer located in the first exon of SENP1 (GACTCTTCCG GTGCTGT) and a primer that hybridizes to the oligodT primer sequences (CUACUACUACUAAAGGATCCGTC GACATC). This PCR was carried out under standard conditions using 10 pmol of priming oligonucleotides. Samples were amplified during 30 cycles in a Perkin Elmer 2400 GeneAmp PCR System. Each cycle included 1 min at 948C, 1 min at 558C and 3 min at 728C. In the first cycle, an extra denaturation step (948C) was included for 1 min and the last Figure 5 . Subcellular localization of MESDC2 (A) and SEME (B), using C-terminal VSV tags and SV40 promoters, after transient expression in HeLa cells. The proteins were visualized using an anti-VSV antibody (green; left panels). Endogenous PDI, an ER resident protein, was visualized with an anti-PDI antibody (red; middle panels). Overlays are shown in the right panels.
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Human Molecular Genetics, 2005, Vol. 14, No. 14 cycle was extended at 728C for 5 min. Subsequently, the PCR sample was diluted 10 times and used for the second PCR step, a hemi-nested PCR. Therefore, the following primers were used: a nested forward primer located in the first exon of SENP1 (CATCATCATCATCTGT GAAGGCGGTTCC) and the reverse primer that hybridizes to the oligodT primer sequences. PCR analyses (35 cycles) included 30 s at 948C, 30 s at 558C and 3 min at 728C. In the first cycle, an extra denaturation step (948C) was included for 2 min and the last cycle was extended at 728C for 5 min. The PCR samples were loaded onto standard agarose gels and bands were sliced out, purified by standard procedures, ligated into pGEM-T vectors (Promega, Leiden, The Netherlands), according to the instructions of the manufacturer, and sequenced using SP6-and T7-specific primers. For additional PCR analyses, the following primers were used: Sprot-exon5r (GAGGTCTTTCGGGTTTCGAGG), Sprot-exon3r (AGCGA AAGCTGGTCCTCTGG), Sprot-raceFnest (CGCATGGCAG CCGGTTCCG), KIAA0081-exon3r (TTGCCCTTGTCTTGC TTTG), KIAA0081-exon1f (TTGTGCCTCTGACCTGCT GC) and KIAA0081-exon2r (CCTTCTCAGTAGGGCTTCC).
Plasmid constructs
On the basis of the published sequences of SENP1 (36) and MESDC2 (GenBank accession nos. KIAA0081 and BC009210) (37, 38) , cDNAs of SENP1, SENP1-MESDC2 (SEME) and MESDC2-SENP1 (MESE) were generated by RT-PCR on RNA extracted from the t(12;15)(q13;q25)-positive cell line using the oligodT primer, the random hexamer mix and Sprotex1-Eco RI-F (CGGAATTCTCTTCCGGTGCTGTGAA GG), Sprotex18-Nhe I-R (CTAGCTAGCTAGGAGTTTTC GGTGGAGGATC) and 5-BC009210-F (GGAATTCGGTAAG CGCGTCTAGGG). For the MESDC2 construct, cDNA was derived from a clone (3637449) of the IMAGE Consortium (58), using a primer specific for the SP6 promoter and 3-Mesdc2-R (GACTAGTGTCTTCTCTTTTATTCCCAGC). These cDNAs were cloned into a eukaryotic expression vector PSG8 (59) in frame with a VSV-tag at their 3 0 end. His-PML and Ha-SUMO-1 constructs were described earlier (36, 60) .
Cellular localization assays
HeLa cells were transfected directly on glass slides using FuGENE 6 (Roche Diagnostics, Mannheim, Germany), according to the instructions of the manufacturer. Immunofluorescence assays were performed essentially as described earlier (61) . The following antibodies were used for immunostaining: the monoclonal mouse anti-VSV antibody (1:1000) (Sigma Genosys, Cambridge, UK) and the rabbit anti-PDI antibody (1:10) (62), followed by appropriate FITC or Texas Red-conjugated goatanti-mouse antibody or goat-anti-rabbit antibody (1:100) (Jackson ImmunoResearch Laboratories Inc., West Grove, PA, USA). Images were recorded using a Zeiss LSM510 META confocal microscope running software release 3.2.
PML desumoylation assay
COS-1 cells were transfected by nucleofection (Amaxa, Koeln, Germany), according to the instructions of the manufacturer, with one or more of the following constructs (displayed in Fig. 4 ): His -PML, Ha -SUMO-1, MESE -VSV (11.4), MESE-VSV (1.2), WT SENP1-VSV or empty vector (PSG8). The cells were washed in ice-cold PBS 24 h after transfection and lysed in ice-cold lysis buffer (50 mM HEPES pH 7.5, 150 mM NaCl, 1.5 mM MgCl 2 , 1 mM EDTA, 0.5% NP-40 and 0.3% Triton X-100) supplemented with protease inhibitors [100Â dilution of 0.5 M DTE, 2 M ethylmaleimide, complete cocktail (Roche Diagnostics) and 100 mM PMSF]. Before IP, aliquotes of the cell lysates were used to assay the expression levels from the different SENP1-VSV constructs. For IP-mediated extraction of the PML conjugates, a monoclonal anti-polyhistidine antibody (Sigma Genosys) was added to the cell lysates (100Â dilution) and mixed by tumbling for minimal 4 h at 48C. Subsequently, protein A beads (Sigma Genosys) were added (10% v/v) after washing with ice-cold lysis buffer and mixed by tumbling for an additional 1 -2 h at 48C. After several washes, the samples (before and after IP) were boiled for 5 min in SDS sample buffer before loading onto SDS polyacrylamide gels (7.5%) and, subsequently, transferred to PROTRAN nitrocellulose membranes (Schleicher and Schuell, Dassel, Germany). For immunodetection of the samples on the membranes, a mouse anti-Ha (1 : 1000), a mouse monoclonal anti-polyhistidine (1 : 3000) and an anti-VSV (1 : 10) (P5D4) antibodies were used. As secondary antibodies, a rabbit-anti-mouse-HRP or a swine-anti-rabbit-HRP was used (1:1000) (DAKO, Denmark). Immunostaining was performed using chemoluminesence.
